Comparison of panretinal photocoagulation (PRP) with PRP plus intravitreal bevacizumab in the treatment of proliferative diabetic retinopathy;Proliferatif diyabetik retinopati tedavisinde tek başina panretinal fotokoagülasyon (PRF) ile PRF ve i̇ntravitreal bevacizumab kombinasyonunun karşilaştirilmasi

Retina-Vitreus

Volumn 17, Issue 4, 2009, Pages 273-277

  Ergür, Özkan ^a   Bayhan, Hasan Ali ^a   Kürkçüoǧlu, Piraye ^a   Takmaz, Tamer ^a   Gürdal, Canan ^a   Can, Izzet ^a  

^a MINISTRY OF HEALTH   (Turkey)

Author keywords

Diabetic retinopathy; Intravitreal bevacizumab; Panretinal photocoagulation

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LASER COAGULATION; PANRETINAL PHOTOCOAGULATION; PROSPECTIVE STUDY; REMISSION; RETINA NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY;

EID: 77953387322     PISSN: 13001256     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Vander JF, Duker JS, Benson WE, et al.: Long term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology. 1991;98:1575-1579.
2. Spaide RF, Fisher YL.: Intravitreal bevacizumab (avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26:275-278.
3. Polat B, Batioǧlu F.: Diabetik retinopatide güncel tibbi tedavi yaklaşimlari. Ret-Vit. 2007;15:153-159.
4. Jorge R, Costa RA, Calucci D, Cintra LP, Scott IU.: Intravitreal bevacizumab (avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina. 2006;26:1006-1013.
5. Diabetic Retinopathy Study Research Group.: Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81:383-396.
6. Shimura M, Yasuda K, Nakazawa T, et al.: Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopahy and good vision. Ophthalmology. 2003;110:2386-2394.
7. Early Treatment Diabetic Retinopathy Study Research Group.: Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98:766-85.
8. Zein WM, Noureddin BN, Jurdi FA, et al.: Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema. Retina. 2006;26:137-142.
9. Bandello F, Polito A, Pognuz DR, et al.: Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol. 2006;124:643-650.
10. Holland H, Tuvel B, Wong J, Sharma S.: Intravitreal triamcinolone acetonide: a review of effectiveness and safety. Evid Base Ophthalmol. 2007;8:55-62.
11. Cerman E, Yenice Ö, Kozakoǧlu H, et al.: Diyabetik retinopatili olgularda serum ve vitreusta leptin ve VEGF seviyeleri. Ret-Vit. 2007;15:21-26.
12. Polat B, Batioǧlu F, Astam N, Özmert E.: Diabetik retinopati tedavisinde intravitreal bevacizumab'in etkinliǧi. MN Oftalmol. 2007;14:255-257.
13. Avery LR, Pearlman J, Pieramici DJ, et al.: Intravitreal bevacizumab (avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113:1695-1705.
14. Mirshahi A, Roohipoor R, Lashay A, et al.: Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: A randomized double-masked clinical trial. Eur J Ophthalmol. 2008;18:263-269.
15. Arevalo JF, Wu L, Sanchez JG, et al.: Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye. 2009;23:117-123.
16. Haritoglou C, Kook D, Neubauer A, et al.: Intravitreal bevacizumab (avastin) therapy for persistent diffuse diabetic macular edema. Retina. 2006;26:999-1005.
17. Mason JO, Yunker JJ, Vail R, Mcgwin G.: Intravitreal bevacizumab (avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy. Retina. 2008;28:1319-1324.
18. Tonello M, Costa RA, Almeida FPP, et al.: Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol. 2008;86:385-389.